Combined [68 Ga]Ga-PSMA-11 and low-dose 2-[18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy

PURPOSE: Performing 2-[(18)F]FDG PET/CT in addition to a PSMA-ligand PET/CT can assist in the detection of lesions with low PSMA expression and may help in prognostication and identification of patients who likely benefit from PSMA-radioligand therapy (PSMA-RLT). However, the cost and time needed fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Ian, Schepers, Robin, Zeimpekis, Konstantinos, Sari, Hasan, Rominger, Axel, Afshar-Oromieh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852199/
https://www.ncbi.nlm.nih.gov/pubmed/36136102
http://dx.doi.org/10.1007/s00259-022-05961-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852199/
https://www.ncbi.nlm.nih.gov/pubmed/36136102
http://dx.doi.org/10.1007/s00259-022-05961-z

Ejemplares similares